Buffered Lidocaine Syringes at Brooke Army Medical Center, JBSA Ft. Sam Houston, TX

SOL #: W81K00-26-Q-A001Combined Synopsis/Solicitation

Overview

Buyer

DEPT OF DEFENSE
Dept Of The Army
W40M MRC0 WEST
JBSA FT SAM HOUSTON, TX, 78234-4504, United States

Place of Performance

DWG, TX

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Medical And Surgical Instruments, Equipment, And Supplies (6515)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Timeline

1
Posted
May 7, 2026
2
Last Updated
Jun 10, 2026
3
Submission Deadline
Jun 10, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of the Army, W40M MRC0 WEST, is soliciting proposals for Buffered Lidocaine Syringes for Brooke Army Medical Center, JBSA Ft. Sam Houston, TX. This is a Combined Synopsis/Solicitation set aside for Total Small Business, with an anticipated Firm Fixed Price arrangement for supplies. The award will be made on a Lowest Price Technically Acceptable (LPTA) basis. Quotes are due by June 10, 2026, at 11:00 AM/CT.

Scope of Work

This opportunity is for the procurement of Buffered Lidocaine Syringes (1% buffered with 8.4% sodium Bicarbonate, 10ml/syringe), to be ordered on an as-needed basis. The requirement includes 6,000 units per Contract Line Item Number (CLIN) for the base year, with options for additional quantities across four option years. Deliveries are FOB Destination to AMC BAMC FSH - MM, JBSA Ft. Sam Houston, TX. Unique Item Identification (IUID) requirements apply, particularly for items costing $5,000 or more.

Contract Details

  • Contract Type: Combined Synopsis/Solicitation, implying Firm Fixed Price for supplies.
  • Period of Performance: Base year from October 1, 2026, to September 30, 2027, with four additional option years extending through September 30, 2031.
  • Set-Aside: Total Small Business Set-Aside (FAR 19.5).
  • NAICS Code: 325412 (Size Standard: 1300 employees).
  • Product Service Code (PSC): 6505 (Medical And Surgical Instruments, Equipment, And Supplies).

Submission & Evaluation

  • Offer Due Date: June 10, 2026, 11:00 AM/CT.
  • Questions Due Date: June 5, 2026, 11:00 AM/CT.
  • Submission Method: Quotes must be emailed to patrick.a.thielemann.civ@health.mil and christopher.a.gregory11.civ@health.mil. Electronic submissions larger than 20MB require separate emails.
  • Evaluation Factors:
    1. Compliance with Specifications: Offerors must provide proof of compliance with federal (FDA) and state regulations for product production/distribution. Unacceptable ratings will lead to ineligibility.
    2. Price: Evaluated for reasonableness, balance, and completeness across all CLINs.
  • Award Basis: Lowest Price Technically Acceptable (LPTA).
  • Quote Firm Period: Offerors must hold quotes firm for at least 90 days.
  • Registration: Potential contractors must be registered in SAM.gov.

Contact Information

People

Points of Contact

Patrick ThielemannPRIMARY
Christopher GregorySECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 3
Combined Synopsis/Solicitation
Posted: Jun 10, 2026
View
Version 2Viewing
Combined Synopsis/Solicitation
Posted: Jun 3, 2026
Version 1
Sources Sought
Posted: May 7, 2026
View